These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32659369)

  • 21. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2.
    Wang S; Xie Y; Liu F; Wang J; Yang Y; Wang J; Wang Y; Hang X
    Arch Virol; 2024 Apr; 169(5):88. PubMed ID: 38565755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
    Tian H; He Z
    Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.
    McDaniel YZ; Patterson SE; Mansky LM
    Antiviral Res; 2019 Oct; 170():104540. PubMed ID: 31247245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
    Cai D; Yan R; Xu JZ; Zhang H; Shen S; Mitra B; Marchetti A; Kim ES; Guo H
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
    Fan HX; Feng YJ; Zhao XP; He YZ; Tang H
    Life Sci; 2018 Nov; 213():9-17. PubMed ID: 30308183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory effects of miR-146a/b on the function of endothelial progenitor cells in acute ischemic stroke in mice.
    Su ZF; Sun ZW; Zhang Y; Wang S; Yu QG; Wu ZB
    Kaohsiung J Med Sci; 2017 Aug; 33(8):369-378. PubMed ID: 28811005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
    Delaney WE; Miller TG; Isom HC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy.
    Lin Y; Deng W; Pang J; Kemper T; Hu J; Yin J; Zhang J; Lu M
    Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27886437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
    Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulation of microRNA-122 on HBV replication by targeting HBx sequence].
    Hao M; Zheng S; Ding H; Huang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):784-9, 803. PubMed ID: 21936381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-501 promotes HBV replication by targeting HBXIP.
    Jin J; Tang S; Xia L; Du R; Xie H; Song J; Fan R; Bi Q; Chen Z; Yang G; Liu J; Shi Y; Fan D
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1228-33. PubMed ID: 23266610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.
    Kumar M; Sharma Y; Bandi S; Gupta S
    J Med Virol; 2015 Jul; 87(7):1168-83. PubMed ID: 25690916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-520a suppresses HBV replication in HepG2.2.15 cells by inactivating AKT.
    Sun W; Zhang J; Chen J
    J Int Med Res; 2018 Nov; 46(11):4693-4704. PubMed ID: 30191752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4.
    Xing T; Zhu J; Xian J; Li A; Wang X; Wang W; Zhang Q
    Life Sci; 2019 Feb; 219():199-208. PubMed ID: 30615846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity.
    Wang S; Qiu L; Yan X; Jin W; Wang Y; Chen L; Wu E; Ye X; Gao GF; Wang F; Chen Y; Duan Z; Meng S
    Hepatology; 2012 Mar; 55(3):730-41. PubMed ID: 22105316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
    Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
    Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.